Investigating a key enzyme's role in vision loss due to eye scarring
"Myeloid PFKFB3 in subretinal fibrosis"
This study is looking at how a certain enzyme affects the growth of scar tissue in the eye that can cause vision problems for people with age-related macular degeneration, and it hopes to find new ways to help prevent this issue and improve treatment options for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-11044992 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific enzyme, Pfkfb3, contributes to the development of subretinal fibrosis, a condition that can lead to severe vision impairment in patients with age-related macular degeneration. By examining the metabolic pathways involved in this process, the study aims to identify potential therapeutic strategies to inhibit the progression of fibrosis. The research involves analyzing various cell types in the eye that contribute to this condition and how they interact with each other and their environment. Patients may benefit from insights gained that could lead to new treatments for vision loss.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with age-related macular degeneration who are experiencing or at risk of developing subretinal fibrosis.
Not a fit: Patients with other forms of vision impairment unrelated to age-related macular degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or reduce vision loss in patients with age-related macular degeneration.
How similar studies have performed: Previous research has shown promising results in targeting metabolic pathways in other fibrotic conditions, suggesting potential for success in this novel approach.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Caldwell, Ruth B — Augusta University
- Study coordinator: Caldwell, Ruth B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.